scispace - formally typeset
J

Junxia Wang

Researcher at South China University of Technology

Publications -  25
Citations -  865

Junxia Wang is an academic researcher from South China University of Technology. The author has contributed to research in topics: Nanocarriers & Drug delivery. The author has an hindex of 13, co-authored 21 publications receiving 617 citations. Previous affiliations of Junxia Wang include Hefei University of Technology.

Papers
More filters
Journal ArticleDOI

Semiconducting polymer-based nanoparticles with strong absorbance in NIR-II window for in vivo photothermal therapy and photoacoustic imaging.

TL;DR: A thieno-isoindigo derivative-based semiconducting polymer, PBTPBF-BT, formulated into PEGylated nanoparticles exhibited strong absorption in NIR-II region, inherent high photothermal conversion efficacy, and excellent photostability, suggesting the great probability of using NPPBTP BF-BT for in vivo PA imaging-guided PTT in the Nir-II window.
Journal ArticleDOI

ROS-Sensitive Polymeric Nanocarriers with Red Light-Activated Size Shrinkage for Remotely Controlled Drug Release

TL;DR: A reactive oxygen species (ROS)-sensitive polymeric nanocarrier TK-PPE@NPCe6/DOX was explored to realize remotely controlled drug release by light-activated size shrinkage by triggering rapid DOX release.
Journal ArticleDOI

The potentiated checkpoint blockade immunotherapy by ROS-responsive nanocarrier-mediated cascade chemo-photodynamic therapy.

TL;DR: The use of cascade chemo-photodynamic therapy with reactive oxygen species (ROS)-sensitive lipid-polymer hybrid nanoparticles TKHNP-C/D to potentiate the antitumor efficacy of anti-PD-L1 antibody to generate an abscopal effect which could simultaneously inhibit primary and distant tumor growth.
Journal ArticleDOI

NIR‐Activated Supersensitive Drug Release Using Nanoparticles with a Flow Core

TL;DR: Polymeric nanoparticles observed with flowable core can achieve NIR‐activated supersensitive drug release under the assistance of photothermal agent, which significantly enhances its anticancer efficacy, resulting in overcoming of the resistance of cancer cells against DOX treatment in vitro and in vivo.
Journal ArticleDOI

A Donor–Acceptor Conjugated Polymer with Alternating Isoindigo Derivative and Bithiophene Units for Near-Infrared Modulated Cancer Thermo-Chemotherapy

TL;DR: In vivo and in vitro experiments demonstrated that PBIBDF-BT@NPPPE exhibits efficient photothermal anticancer efficacy and could simultaneously encapsulate other types of therapeutic agents though hydrophobic interactions with the PHEP core and achieve NIR-triggered intracellular drug release and a synergistic combination therapy of thermo-chemotherapy for the treatment of cancer.